Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015

pdf

Nectar Lifesciences Ltd.

11 Jun 2025

18.88

-5.03%

Company Update

Nectar Lifesciences Ltd - 532649 - Disclosure As Per Regulation 30 Of The Securities And Exchange …

BSE India

Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015

pdf

Nectar Lifesciences Ltd.

30 May 2025

18.88

-5.03%

Company Update

Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Please find attached herewith change in Directors as per letter.

pdf

Nectar Lifesciences Ltd.

30 May 2025

18.88

-5.03%

Result

Nectar Lifesciences Ltd - 532649 - Results-Delay in Financial Results

BSE India

Please find attached herewith the reason for delay in financial results for the quarter and year ended on March 31, 2025.

pdf

Nectar Lifesciences Ltd.

30 May 2025

18.88

-5.03%

Board Meeting

Nectar Lifesciences Ltd - 532649 - Board Meeting Outcome for Change In Directorate

BSE India

Nectar Lifesciences Limited has informed the Exchange regarding outcome of Board meeting held on May 30, 2025 regarding the Change in Directorate. The Audit Committee and Board of Directors could not approve and take on record the Audited Financial Results and Financial Statements for the quarter and year ended March 31, 2025. Therefore, the meetings stand adjourned sine die, for said matters. The reasons for delay in submission of financial results is being submitted by way of separate letter

pdf

Nectar Lifesciences Ltd.

28 May 2025

18.88

-5.03%

Company Update

Nectar Lifesciences Ltd - 532649 - Disclosure As Per Regulation 30 Of The Securities And Exchange …

BSE India

Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015

pdf

Nectar Lifesciences Ltd.

27 May 2025

18.88

-5.03%

Board Meeting

Nectar Lifesciences Ltd - 532649 - Board Meeting Intimation for Annual Audited Financial Results And Other …

BSE India

Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2024-25, Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto.

pdf

Nectar Lifesciences Ltd.

08 May 2025

18.88

-5.03%

Company Update

Nectar Lifesciences Ltd - 532649 - Disclosure As Per Regulation 30 Of The Securities And Exchange …

BSE India

Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015

pdf

Is Nectar Lifesciences Ltd. worth buying?

162 Votes:

Buy 77.78%

Sell 16.67%

Hold 5.56%

New 52W Low in past week

High vol.+loss this week

Nectar Lifesciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nectar Lifesciences Ltd. on BSE